Trial Profile
A Single Center, Retrospective Study Investigating the Efficacy and Safety of Apatinib in Metastatic Breast Cancer (MBC) Patients in Non-Clinical Trial Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 Aug 2017 New trial record